|
[1] FATEHI HASSANABAD A. Current perspectives on statins as potential anti-cancer therapeutics:Clinical outcomes and underlying molecular mechanisms[J]. Transl Lung Cancer Res,2019,8(5):692-699.
|
|
[2] BUTT AA,YAN P,BONILLA H,et al. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons:Results from ERCHIVES[J]. Hepatology,2015,62(2):365-374.
|
|
[3] HSIANG JC,WONG GL,TSE YK,et al. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population:A propensity score landmark analysis[J]. J Hepatol,2015,63(5):1190-1197.
|
|
[4] DOUMAS M,IMPRIALOS K,DIMAKOPOULOU A,et al. The role of statins in the management of nonalcoholic fatty liver disease[J]. Curr Pharm Des,2018,24(38):4587-4592.
|
|
[5] YI SW,KIM SH,HAN KJ,et al. Higher cholesterol levels,not statin use,are associated with a lower risk of hepatocellular carcinoma[J]. Br J Cancer,2020,122(5):630-633.
|
|
[6] BRAEUNING A,BUCHER P,HOFMANN U,et al. Chemically induced mouse liver tumors are resistant to treatment with atorvastatin[J]. BMC Cancer,2014,14:766.
|
|
[7] QIN WH,YANG ZS,LI M,et al. High serum levels of cholesterol increase antitumor functions of nature killer cells and reduce growth of liver tumors in mice[J]. Gastroenterology,2020,158(6):1713-1727.
|
|
[8] ZHAO Z,ZHONG L,HE K,et al. Cholesterol attenuated the progression of DEN-induced hepatocellular carcinoma via inhibiting SCAP mediated fatty acid de novo synthesis[J]. Biochem Biophys Res Commun,2019,509(4):855-861.
|
|
[9] GBEL A,RAUNER M,HOFBAUER LC,et al. Cholesterol and beyond-The role of the mevalonate pathway in cancer biology[J]. Biochim Biophys Acta Rev Cancer,2020,1873(2):188351.
|
|
[10] CHOU CW,LIN CH,HSIAO TH,et al. Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis[J]. Sci Rep,2019,9(1):20403.
|
|
[11] KOPECKA J,TROUILLAS P,GAPAROVIC'ACCˇ，et al. Phospholipids and cholesterol:Inducers of cancer multidrug resistance and therapeutic targets[J]. Drug Resist Updat,2020,49:100670.
|
|
[12] ZHAO Y,WU TY,ZHAO MF,et al. The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease[J]. J Biol Chem,2020,295(15):5152-5162.
|
|
[13] JIANG P,MUKTHAVARAM R,CHAO Y,et al. In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells[J]. Br J Cancer,2014,111(8):1562-1571.
|
|
[14] PRASAD S,GUPTA SC,TYAGI AK. Reactive oxygen species(ROS)and cancer:Role of antioxidative nutraceuticals[J].Cancer Lett,2017,387:95-105.
|
|
[15] JANG HJ,HONG EM,KIM M,et al. Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2(Nrf2)activation through ERK and PI3K/Akt pathway in colon cancer[J]. Oncotarget,2016,7(29):46219-46229.
|
|
[16] GORABI AM,KIAIE N,HAJIGHASEMI S,et al. Statin-induced nitric oxide signaling:Mechanisms and therapeutic implications[J]. J Clin Med,2019,8(12):2051.
|
|
[17] ROSSONI LV,WAREING M,WENCESLAU CF,et al. Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries[J].Clin Sci(Lond),2011,121(10):449-458.
|
|
[18] COLOTTA F,ALLAVENA P,SICA A,et al. Cancer-related inflammation,the seventh hallmark of cancer:Links to genetic instability[J]. Carcinogenesis,2009,30(7):1073-1081.
|
|
[19] RIDKER PM. From C-reactive protein to interleukin-6 to interleukin-1:Moving upstream to identify novel targets for atheroprotection[J]. Circ Res,2016,118(1):145-156.
|
|
[20] WEI TT,LIN YT,CHEN WS,et al. Dual targeting of 3-hydroxy-3-methylglutaryl coenzyme a reductase and histone deacetylase as a therapy for colorectal cancer[J]. EBio Medicine,2016,10:124-136.
|
|
[21] WIELAND E,RODRIGUEZ-VITA J,LIEBLER SS,et al. Endothelial Notch1 Activity facilitates metastasis[J]. Cancer Cell,2017,31(3):355-367.
|
|
[22] LIU S,UPPAL H,DEMARIA M,et al. Simvastatin suppresses breast cancer cell proliferation induced by senescent cells[J]. Sci Rep,2015,5:17895.
|
|
[23] KUBATKA P,KRUZLIAK P,ROTREKL V,et al. Statins in oncological research:From experimental studies to clinical practice[J]. Crit Rev Oncol Hematol,2014,92(3):296-311.
|
|
[24] KIMBUNG S,LETTIERO B,FELDT M,et al. High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer[J].Oncotarget,2016,7(37):59640-59651.
|
|
[25] CHEN Y,KU H,ZHAO L,et al. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-Co A reductase feedback regulation[J]. Arterioscler Thromb Vasc Biol,2014,34(2):365-376.
|
|
[26] NISHIKAWA S,MENJU T,TAKAHASHI K,et al. Statins may have double-edged effects in patients with lung adenocarcinoma after lung resection[J]. Cancer Manag Res,2019,11:3419-3432.
|
|
[27] MOON SH,HUANG CH,HOULIHAN SL,et al. p53 Represses the mevalonate pathway to mediate tumor suppression[J]. Cell,2019,176(3):564-580. e19.
|
|
[28] RAGHU VK,BECKWITT CH,WARITA K,et al. Biomarker identification for statin sensitivity of cancer cell lines[J]. Biochem Biophys Res Commun,2018,495(1):659-665.
|
DownLoad: